Latest / Stock Movers / WBD to Reject Paramount Offer, Molina, Ultragenyx Rise
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news.
- 0:08Speaker 2: The Stock Mover's Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg data. Well,
- 0:16Speaker 2: let's get to our individual movers now.
- 0:19Speaker 1: She's been keeping an eye on them all day long,
- 0:20Speaker 1: and with less than an hour in the trading day
- 0:23Speaker 1: to go, we do have one more day in the year.
- 0:25Speaker 1: Nora Wan then joins us in the studio. Norah.
- 0:28Speaker 3: Well, Bonnie, let's circle back to that story that this is,
- 0:31Speaker 3: of course, Warner Brothers plan to reject a paramount's offer
- 0:34Speaker 3: next week. This is another offer that Paramount has been
- 0:37Speaker 3: giving Warner Brothers Discovery. They've been reiterating the fact that
- 0:40Speaker 3: they prefer Netflix's offer. This is a Bloomberg exclusive. So
- 0:43Speaker 3: we are seeing shares not too much of a reaction here,
- 0:46Speaker 3: but we are seeing Warner Brothers Discovery shares climbing higher,
- 0:49Speaker 3: up as much as seven tenths of a percent. Paramount's
- 0:52Speaker 3: guidance is pulling back from its earlier interday high that
- 0:54Speaker 3: we saw, so it's now up about just about flat
- 0:58Speaker 3: right now. Actually, So it's interesting, is people really trying
- 1:00Speaker 3: to digest what's going to happen with this story, this saga,
- 1:03Speaker 3: this back and forth that we've been seeing in terms
- 1:05Speaker 3: of us really looking to see whether or not there'll
- 1:07Speaker 3: be some m and a action to come. Looks like
- 1:09Speaker 3: it's bleeding into twenty twenty six indigestion over this.
- 1:13Speaker 1: If Netflix wins and then makes a Netflix series on
- 1:15Speaker 1: it would be right.
- 1:16Speaker 3: Now, that would be interesting. There's a tip for them.
- 1:19Speaker 2: It does.
- 1:19Speaker 1: It does read like a you know, a series. I mean,
- 1:22Speaker 1: we should point out that Warner Brothers has had quite
- 1:24Speaker 1: a pop to the upside, and actually it's just this
- 1:26Speaker 1: maneuvering but yeah, you're right, like the content here would
- 1:29Speaker 1: certainly read well.
- 1:29Speaker 3: Yeah, shares are up one hundred and seventy four percent
- 1:32Speaker 3: year today for Warner Brothers Discovery.
- 1:33Speaker 1: All right, we're gonna be talking about this one in
- 1:35Speaker 1: the new year. Hey, let's go to a story on
- 1:38Speaker 1: stock that is definitely popping in today's sessions, up about
- 1:40Speaker 1: three and a quarter percent as we speak.
- 1:42Speaker 3: Yes, looking at shares a Malina Healthcare. This has been
- 1:44Speaker 3: a stock that's been hanging as the best performing stock
- 1:46Speaker 3: in the s and P five hundred. I mean, I
- 1:48Speaker 3: guess it is also a point important to point out
- 1:50Speaker 3: that it's low trading activity right now, but we've been
- 1:53Speaker 3: keeping our eyes on this name. Nonetheless, take our moh
- 1:56Speaker 3: we're seeing shares up as much as four point eight percent. Now,
- 2:00Speaker 3: what's up about three point three percent? But this is
- 2:02Speaker 3: after Michael Berry, who people still maintain their eyes on.
- 2:05Speaker 3: He made a substack post that essentially was highlighting the
- 2:08Speaker 3: company's record of strong expense ratios and underwriting results, also
- 2:12Speaker 3: praising the company's acquisition strategies. So this is just interesting
- 2:16Speaker 3: as Michael Burry's essentially saying that this company is best
- 2:18Speaker 3: positioned to emerge stronger as a cycle turns in relation
- 2:22Speaker 3: to its competitors. Here, Caryl and.
- 2:24Speaker 1: Still somebody that everybody reads and takes very very seriously
- 2:27Speaker 1: as they should. Right talk to us about some of
- 2:30Speaker 1: these biotechs that are making crazy moves this week.
- 2:33Speaker 2: And another one today.
- 2:34Speaker 3: Yes, another one. We're seeing sharers of Ultra Genics Pharmaceutical.
- 2:38Speaker 3: This is ticker Rare jumping for double digit returns right
- 2:42Speaker 3: now on the day. We're seeing this as the best
- 2:45Speaker 3: performance we've seen from the stock since August of twenty
- 2:47Speaker 3: twenty four. This is a rebound after the stock hit
- 2:49Speaker 3: a record low just yesterday. On a study failure. We're
- 2:53Speaker 3: seeing Jeffrey's analysts saying that the stock could continue to
- 2:56Speaker 3: rebound in twenty twenty six ahead of a late stage
- 2:59Speaker 3: data updates that is expected. So when you look at
- 3:02Speaker 3: shares of the stock though, down about forty seven percent
- 3:05Speaker 3: so far this year, so a brutal year. We'll have
- 3:07Speaker 3: to see if it can actually eke out a turnaround.
- 3:09Speaker 1: Yeah, nearly ten percent of the float is short too,
- 3:11Speaker 1: so there's some negative sentiment out there.
- 3:15Speaker 2: The Stock Movers report from Bloomberg Radio. Check back with
- 3:19Speaker 2: us throughout the day for the latest roundup of companies
- 3:21Speaker 2: making news on Wall Street and for the latest market
- 3:25Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 3:29Speaker 2: Bloomberg dot com, and on applecarplay and Android Auto with
- 3:33Speaker 2: the Bloomberg Business app.